Introduction to the ULYSSES Trial

Atrial fibrillation (AF) catheter ablation is a cornerstone of modern arrhythmia management. However, vascular access site complications remain the most frequent procedure-related adverse events. Recently, the ULYSSES trial investigated whether ultrasound-guided venous puncture could effectively mitigate these risks compared to the traditional palpation-guided approach. Consequently, researchers conducted this multicenter superiority trial to provide definitive evidence for clinical practice.

Significant Reduction in Complications

Notably, the trial enrolled 986 patients across six specialized centers. The study group randomized 496 patients to receive the intervention, while 490 patients served as the control group. Therefore, the researchers evaluated a robust sample size. Remarkably, the trial committee stopped the study early for efficacy after the first interim analysis. Results showed that the composite primary outcome—including arteriovenous fistula and false aneurysms—occurred in only 0.6% of the intervention group compared to 3.3% in the control group. Furthermore, this represents a significant risk reduction with a P-value of 0.002.

Benefits of Ultrasound-Guided Venous Puncture

Beyond the primary outcome, the study highlighted several secondary benefits. For instance, the rate of unintended arterial punctures plummeted from 16% in the conventional group to just 2% in the ultrasound group. Additionally, clinicians reported fewer failed venous access attempts when using imaging guidance. These findings suggest that ultrasound-guided venous puncture not only enhances safety but also improves procedural efficiency. Moreover, reducing these minor yet frequent complications can potentially shorten hospital stays and lower overall healthcare costs.

Conclusion for Clinical Practice

In conclusion, the ULYSSES trial provides high-quality evidence supporting the routine use of ultrasound for femoral access. Since vascular complications can lead to prolonged hospitalization and patient discomfort, adopting this imaging strategy is logical. Consequently, electrophysiologists should consider integrating real-time ultrasound guidance into their standard workflow for all left atrial tachycardia catheter ablations.

Frequently Asked Questions

What was the primary finding of the ULYSSES trial?

The trial found that ultrasound guidance reduced the rate of venous access site complications from 3.3% to 0.6% during atrial fibrillation ablation.

Did ultrasound guidance reduce arterial punctures?

Yes, unintended arterial punctures were significantly lower in the ultrasound group, occurring in only 2% of cases compared to 16% in the conventional group.

Why was the ULYSSES trial stopped early?

The trial was stopped for efficacy because the interim analysis demonstrated a clear and significant benefit for the ultrasound-guided approach.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Practitioners should always rely on their clinical judgment and refer to the latest local and national guidelines for clinical practice.

References

1. Schaack D et al. Ultrasound-guided vs conventional venous puncture for atrial fibrillation ablation: the ULYSSES trial. Eur Heart J. 2026 Apr 14. doi: undefined. PMID: 41979041.


2. Eshraghi R, et al. Ultrasound-guided versus anatomic landmark-guided vascular access in cardiac electrophysiology procedures: A systematic review and meta-analysis. PMC. 2022 Feb 7.


3. Watanabe T, et al. Ultrasound-guided versus conventional femoral venipuncture for catheter ablation of atrial fibrillation: the ULTRA-FAST trial. Europace. 2017 Jul 1.